Tissue Regenix Group PLC (TRX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
36.00p
Buy
38.00p
-1.00p (-2.63%)
Tissue Regenix Group PLC is a biotechnology company. Its business includes the development of regenerative products using its dcell technology.
Prices updated at 20 Mar 2025, 16:30 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
---|---|---|---|---|---|
2023 | 47.60 | -1.34 | -5.81 | 1.51 | 0m |
2022 | 46.00 | -8.21 | -11.01 | -3.89 | -1m |
2021 | 42.93 | -20.37 | -24.27 | -17.01 | -3m |
2020 | 45.95 | -32.51 | -75.68 | -69.96 | -12m |
2019 | 46.18 | -55.08 | -53.50 | -47.08 | -8m |
2018 | 50.93 | -71.14 | -70.45 | -64.07 | -9m |
2017 | 49.80 | -185.71 | -176.21 | -192.28 | -14m |
2016 | 81.13 | -1,255.15 | -1,153.19 | -1,225.12 | -14m |
Valuation data table
Year | Price / Sales | Price earnings | Price / Cash flow |
---|---|---|---|
2025 | 1.10 | - | 97.34 |
2024 | 1.67 | - | 148.35 |
2023 | 1.74 | - | - |
2022 | 2.16 | - | - |
2021 | 2.69 | - | - |
2020 | 0.58 | - | - |
2019 | 1.01 | - | - |
2018 | 7.36 | - | - |
2017 | 57.87 | - | - |
2016 | 117.23 | - | - |
2015 | 292.81 | - | - |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
---|---|---|---|
2023 | -3.84 | -5.58 | -1.51 |
2022 | -5.84 | -8.22 | -4.86 |
2021 | -9.93 | -13.06 | -9.32 |
2020 | -27.60 | -34.59 | -28.99 |
2019 | -20.83 | -24.38 | -21.20 |
2018 | -18.95 | -21.66 | -21.19 |
2017 | -31.70 | -36.41 | -36.57 |
2016 | -51.41 | -56.06 | -57.26 |
Debt profile data table
Year | Financial leverage |
---|---|
2023 | 1.43 |
2022 | 1.47 |
2021 | 1.35 |
2020 | 1.29 |
2019 | 1.21 |
2018 | 1.14 |
2017 | 1.15 |
2016 | 1.09 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.